The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 22, 2024

Filed:

Aug. 02, 2021
Applicants:

Crispr Therapeutics Ag, Zug, CH;

Bayer Healthcare Llc, Whippany, NJ (US);

Inventors:

Mariacarmela Allocca, Cambridge, MA (US);

Akiko Noma, Cambridge, MA (US);

Abraham Scaria, Cambridge, MA (US);

Assignees:

CRISPR THERAPEUTICS AG, Zug, CH;

BAYER HEALTHCARE LLC, Whippany, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); A61K 35/12 (2015.01); A61K 48/00 (2006.01); A61P 27/02 (2006.01); C12N 9/22 (2006.01); C12N 15/86 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/11 (2013.01); A61K 35/12 (2013.01); A61K 48/0066 (2013.01); A61P 27/02 (2018.01); C12N 9/22 (2013.01); C12N 15/86 (2013.01); A61K 38/00 (2013.01); C12N 2310/20 (2017.05); C12N 2750/14132 (2013.01); C12N 2750/14143 (2013.01); C12N 2800/80 (2013.01);
Abstract

The present application provides materials and methods for treating a patient with one or more of Usher Syndrome Type 2A and ARRP, both ex vivo and in vivo; materials and methods for editing an USH2A gene containing a guanine deletion at nucleotide position c.2299. In addition, the present application provides one or more gRNAs or sgRNAs for editing an USH2A gene containing a guanine deletion at nucleotide position c.2299; a therapeutic comprising at least one or more gRNAs or sgRNAs for editing an USH2A gene containing a guanine deletion at nucleotide position c.2299; and a therapeutic for treating a patient with one or more of Usher Syndrome Type 2A and ARRP. The present application also provides a kit for treating a patient with one or more of Usher Syndrome Type 2A and ARRP.


Find Patent Forward Citations

Loading…